Holen Sie sich die Stockscreener-App
10.68
5.01%
0.51
Handel nachbörslich:
11.38
0.70
+6.55%
Schlusskurs vom Vortag:
$10.17
Offen:
$10.18
24-Stunden-Volumen:
507.67K
Relative Volume:
1.26
Marktkapitalisierung:
$722.38M
Einnahmen:
$568.09M
Nettoeinkommen (Verlust:
$27.27M
KGV:
32.60
EPS:
0.3276
Netto-Cashflow:
$71.41M
1W Leistung:
+7.23%
1M Leistung:
+19.06%
6M Leistung:
+44.72%
1J Leistung:
+51.92%
1-Tages-Spanne:
$10.12
$10.73
1-Wochen-Bereich:
$9.565
$10.73
52-Wochen-Spanne:
$5.81
$10.76
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Compare BVS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
10.68 | 687.88M | 568.09M | 27.27M | 71.41M | 0.3276 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | CJS Securities | Market Outperform |
| 2026-02-09 | Eingeleitet | Barrington Research | Outperform |
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Should Value Investors Buy Bioventus (BVS) Stock? - Yahoo Finance
Bioventus Shareholder Notice - TMX Newsfile
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - Yahoo Finance Australia
Bioventus Inc. (NASDAQ:BVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
Earnings Preview: Bioventus to Report Financial Results Pre-market on May 06 - Moomoo
Bioventus Q1 Earnings: Can It Sustain Momentum After a Strong 2025? - BriefGlance
Bioventus schedules May 6 earnings release, 8:30 a.m. call - Stock Titan
(BVS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Bioventus Deadline Alert - TMX Newsfile
BVS Earnings History & Surprises | EPS & Revenue Results | BIOVENTUS INCA (NASDAQ:BVS) - ChartMill
Bioventus Inc. ($BVS) CEO 2025 Pay Revealed - Quiver Quantitative
Bioventus (NASDAQ: BVS) sets 2026 virtual meeting, director slate and auditor vote - Stock Titan
Bioventus Inc. Class A Common Stock (BVS) Stock Price Today & Analysis - Gotrade
Bioventus (BVS) Stock: Buy or Sell? (Technical Strength) 2026-04-18Strong Buy Rating - Newser
Strength seen in Bioventus (BVS): Can its 6.6% jump turn into more strength? - MSN
Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength? - Yahoo Finance
Unaccepted RSU grant corrected for Bioventus (NASDAQ: BVS) director - Stock Titan
Bioventus (BVS) director amends filing on unaccepted 9,000 RSU grant - Stock Titan
Bioventus (BVS) CFO exercises 13,000 RSUs and withholds 5,648 shares for tax - Stock Titan
[Form 4] Bioventus Inc. Insider Trading Activity - Stock Titan
Bioventus (BVS) SVP gains 9,925 shares from RSU vesting, with tax withholding - Stock Titan
Bioventus (NASDAQ:BVS) Hits New 1-Year HighWhat's Next? - MarketBeat
(BVS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Are Investors Undervaluing Bioventus (BVS) Right Now? - Yahoo Finance
Aug Movers: Is Bioventus Inc stock showing strong momentumRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Is Bioventus (BVS) Stock in a Downtrend | Price at $9.04, Down 0.22%Weak Sell Rating - Newser
JPMorgan Chase Trims Stake in Bioventus Inc. - National Today
JPMorgan Chase & Co. Cuts Stock Position in Bioventus Inc. $BVS - MarketBeat
Bone Growth Stimulator Market size to exceed $2.83 Billion - openPR.com
Momentum Shift: Is Bioventus Inc stock showing strong momentum2026 Market Outlook & AI Driven Stock Reports - baoquankhu1.vn
Stop Loss: Is Bioventus Inc exposed to currency risksEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Bioventus Inc. (NASDAQ:BVS) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Investor Mood: Is Bioventus Inc exposed to currency risksWeekly Profit Recap & Safe Capital Growth Tips - baoquankhu1.vn
BVS.O Technical Analysis & Stock Price Forecast - Intellectia AI
BVS Should I Buy - Intellectia AI
BVS.O PE Ratio & Valuation, Is BVS.O Overvalued - Intellectia AI
BVS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BVS News & Events - Intellectia AI
(BVS) Risk Channels and Responsive Allocation - Stock Traders Daily
Surprises Report: Is Bioventus Inc in a bullish channel2026 Gainers & Daily Technical Stock Forecast Reports - baoquankhu1.vn
BVS PE Ratio & Valuation, Is BVS Overvalued - Intellectia AI
CJS Securities Initiates Coverage on Bioventus (NASDAQ:BVS) - Defense World
BVS Technical Analysis & ETF Price Forecast - Intellectia AI
What is market pressure on Bioventus (BVS) Stock | Price at $9.06, Up 0.06%Expert Verified Trades - Cổng thông tin điện tử Tỉnh Sơn La
Bioventus (BVS) CFO vests 18,625 RSUs with 8,091 shares withheld for taxes - Stock Titan
(BVS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bioventus Inc.(NasdaqGS: BVS) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
BVS Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Aug Wrap: Does Bioventus Inc offer margin of safetyEarnings Growth Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Barrington Research initiates coverage of Bioventus (BVS) with outperform recommendation - MSN
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):